Altria Group, Inc. MO

Zacks Investment Research 13 nov

Flowers Foods (FLO) reported Q3 fiscal 2026 earnings of 10 cents per share, down 56.5% year-over-year, missing consensus estimates. Net sales declined 4.7% to $1,169.1 million due to lower volumes, increased promotional activity, and higher operating costs. The company faces headwinds from constrained consumer budgets and shifting preferences toward affordable products. Management lowered full-year fiscal 2026 guidance, expecting net sales decline of 3.7-4.6% and adjusted EBITDA between $415-430 million, down from prior projections.

Zacks Investment Research 13 nov

The iShares Select Dividend ETF (DVY) is a smart beta ETF offering broad exposure to large cap value stocks with a 3.29% dividend yield and 0.38% expense ratio. Managed by BlackRock with $23.71 billion in assets, DVY tracks the Dow Jones U.S. Select Dividend Index and has delivered 17.76% returns year-to-date. The fund holds 104 stocks with top positions in Pfizer, Altria, and HP, heavily weighted toward Financials, Utilities, and Consumer Staples sectors.

Zacks Investment Research 12 nov

With inflation rising more than expected in October and the Federal Reserve likely to implement another rate hike, Zacks recommends three defensive consumer staples stocks: Lamb Weston Holdings, J.M. Smucker Company, and Altria Group. All three stocks feature low betas, solid dividend yields, and positive earnings growth projections, making them suitable defensive plays during economic uncertainty.

Zacks Investment Research 11 nov

B&G Foods (BGS) delivered strong Q3 fiscal 2026 results with adjusted EPS jumping 40% to 21 cents and net sales rising 4.7% to $459.8 million. The company raised its full-year sales and adjusted EBITDA guidance, benefiting from higher volumes, portfolio acquisitions, and margin expansion. However, the stock has declined 43% over the past year amid ongoing leverage reduction efforts.

The Motley Fool 10 nov

Altria Group offers an attractive 5.66% dividend yield with a strong track record of 61 dividend increases over 57 years. The tobacco company generates substantial cash flow from its established Marlboro brand and is diversifying into smoke-free alternatives like nicotine pouches through its on! brand. Trading at a forward P/E of 13x, it presents a compelling opportunity for income investors despite facing long-term headwinds from declining cigarette consumption and regulatory pressures.